ATAI
Price
$2.17
Change
+$0.06 (+2.84%)
Updated
Jun 25, 12:49 PM (EDT)
Capitalization
444.67M
54 days until earnings call
XOMAO
Price
$25.37
Change
+$0.07 (+0.28%)
Updated
Jun 24 closing price
Capitalization
N/A
Interact to see
Advertisement

ATAI vs XOMAO

Header iconATAI vs XOMAO Comparison
Open Charts ATAI vs XOMAOBanner chart's image
ATAI Life Sciences
Price$2.17
Change+$0.06 (+2.84%)
Volume$478
Capitalization444.67M
XOMA
Price$25.37
Change+$0.07 (+0.28%)
Volume$4.08K
CapitalizationN/A
ATAI vs XOMAO Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. XOMAO commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and XOMAO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ATAI: $2.02 vs. XOMAO: $25.30)
Brand notoriety: ATAI and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 206% vs. XOMAO: 44%
Market capitalization -- ATAI: $444.67M vs. XOMAO: $0
ATAI [@Biotechnology] is valued at $444.67M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, ATAI is a better buy in the long-term than XOMAO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish.

  • ATAI’s TA Score: 4 bullish, 4 bearish.

Price Growth

ATAI (@Biotechnology) experienced а -9.82% price change this week, while XOMAO (@Biotechnology) price change was -0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.91%. For the same industry, the average monthly price growth was +35.46%, and the average quarterly price growth was +17.29%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI YTD gains are higher at: 58.647 vs. XOMAO (2.768). XOMAO has higher annual earnings (EBITDA): 6M vs. ATAI (-145.09M). ATAI has more cash in the bank: 98.2M vs. XOMAO (92.6M). ATAI has less debt than XOMAO: ATAI (26.7M) vs XOMAO (114M). XOMAO has higher revenues than ATAI: XOMAO (13M) vs ATAI (1.86M).
ATAIXOMAOATAI / XOMAO
Capitalization445MN/A-
EBITDA-145.09M6M-2,418%
Gain YTD58.6472.7682,119%
P/E RatioN/AN/A-
Revenue1.86M13M14%
Total Cash98.2M92.6M106%
Total Debt26.7M114M23%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDVYX13.96N/A
N/A
Hartford International Equity Y
UMBHX27.67N/A
N/A
Carillon Chartwell Small Cap I
AXVNX17.32N/A
N/A
Acclivity Small Cap Value N
NBPIX47.12N/A
N/A
Neuberger Berman Large Cap Value Instl
KTCSX41.85N/A
N/A
DWS Science and Technology S

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+4.46%
MNMD - ATAI
54%
Loosely correlated
+7.52%
CRSP - ATAI
46%
Loosely correlated
+2.70%
RXRX - ATAI
46%
Loosely correlated
+8.07%
CYBN - ATAI
46%
Loosely correlated
+5.80%
COUR - ATAI
45%
Loosely correlated
+1.78%
More

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.21%
AMLX - XOMAO
68%
Closely correlated
-0.59%
XOMAP - XOMAO
31%
Poorly correlated
+0.23%
ATAI - XOMAO
24%
Poorly correlated
-18.55%
LTRN - XOMAO
23%
Poorly correlated
-3.46%
KALV - XOMAO
23%
Poorly correlated
-1.81%
More